Grant: Doctoral Research Award: Canada Graduate Scholarships
McMaster University
$105,000.00
Microbial lysophosphatidylcholine (LPC) and lysophosphatidic acid (LPA) as mediators in inflammaging-induced chronic constipation and neurodegeneration
FY 2023-24
Summary
Many individuals with neurodegenerative disorders suffer from gastrointestinal symptoms, particularly constipation. The underlying mechanism of the co-occurrence of neurodegeneration and constipation is not well understood. However, the proinflammatory mediator IL-6, which is elevated in individuals with neurodegenerative disorders and chronic constipation, may be the crucial link between gut and brain health.
We hypothesize that the abnormally high levels of IL-6 that contribute to both neurodegenerative diseases and chronic constipation may begin with the bacteria in the gut. More specifically, we believe that certain pro-inflammatory phospholipids that gut bacteria produce by metabolizing ingested food is what drives the systemic and chronic low-grade inflammation underlying these diseases.
To investigate this hypothesis, we will use germ-free mice and colonize them with human bacteria previously identified as producers of these pro-inflammatory phospholipids. A combination of techniques will be used to assess the effects of the bacteria on inflammation, as well as on gut and brain health. Additionally, fecal samples from patients with neurodegeneration, with and without constipation, will be compared to those obtained from healthy age-matched volunteers. Afterwards, an array of microbiological techniques will be used to compare the relative abundance of bacteria producing pro-inflammatory phospholipids between groups. Finally, complete gut bacterial communities from these patients will be used to recreate gut and brain dysfunction in a mouse model and to assess the effects of a standard diet and a diet rich in phospholipids, that contains precursors of pro-inflammatory lipids. Our research will help in understanding the mechanisms underlying the link between chronic constipation and neurodegeneration, and enable the design of novel treatments targeting gut bacteria.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
496469
Name
Hall-Bruce Mikayla
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Microbial lysophosphatidylcholine (LPC) and lysophosphatidic acid (LPA) as mediators in inflammaging-induced chronic constipation and neurodegeneration
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Chronic Constipation; Gut Microbiome; Gut-Brain Axis; Inflammation; Microbiome Analysis; Mouse Models; Neurodegeneration; Phospholipid Metabolism
Abstract
Many individuals with neurodegenerative disorders suffer from gastrointestinal symptoms, particularly constipation. The underlying mechanism of the co-occurrence of neurodegeneration and constipation is not well understood. However, the proinflammatory mediator IL-6, which is elevated in individuals with neurodegenerative disorders and chronic constipation, may be the crucial link between gut and brain health.
We hypothesize that the abnormally high levels of IL-6 that contribute to both neurodegenerative diseases and chronic constipation may begin with the bacteria in the gut. More specifically, we believe that certain pro-inflammatory phospholipids that gut bacteria produce by metabolizing ingested food is what drives the systemic and chronic low-grade inflammation underlying these diseases.
To investigate this hypothesis, we will use germ-free mice and colonize them with human bacteria previously identified as producers of these pro-inflammatory phospholipids. A combination of techniques will be used to assess the effects of the bacteria on inflammation, as well as on gut and brain health. Additionally, fecal samples from patients with neurodegeneration, with and without constipation, will be compared to those obtained from healthy age-matched volunteers. Afterwards, an array of microbiological techniques will be used to compare the relative abundance of bacteria producing pro-inflammatory phospholipids between groups. Finally, complete gut bacterial communities from these patients will be used to recreate gut and brain dysfunction in a mouse model and to assess the effects of a standard diet and a diet rich in phospholipids, that contains precursors of pro-inflammatory lipids. Our research will help in understanding the mechanisms underlying the link between chronic constipation and neurodegeneration, and enable the design of novel treatments targeting gut bacteria.
Competitiondate
202311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Hall-Bruce, Mikayla
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~